Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity.
Fiche publication
Date publication
mars 2019
Journal
Rheumatology (Oxford, England)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NAMER Izzie-Jacques, Pr GOTTENBERG Jacques-Eric, Pr GENY Bernard
Tous les auteurs :
Matuszak J, Blondet C, Hubelé F, Gottenberg JE, Sibilia J, Bund C, Geny B, Namer IJ, Meyer A
Lien Pubmed
Résumé
To devise a simple PET-CT score for measurement of muscle disease activity in patients with inflammatory myopathies (IMs) and to assess its validity.
Mots clés
FDG PET-CT, antisynthetase syndrome, dermatomyositis, inclusion body myositis, inflammatory myopathies, mysoitis, polymyositis, radionuclide imaging, therapeutic assessment
Référence
Rheumatology (Oxford). 2019 Mar 8;: